Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

    Funding for ongoing dental and craniofacial clinical trials from NIDCR.

    OverviewSimilar Grants
    OverviewSimilar Grants

    NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

    Grant supports planning & implementing clinical trials in dental research through UG3/UH3 cooperative agreement applications with NIDCR.

    HHS-NIH11Due Feb 8, 2027

    NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

    This grant supports planning and implementing behavioral and social intervention clinical trials related to dental, oral, or craniofacial conditions, with a two-year planning phase (UG3) and potential transition to a five-year clinical trial implementation phase (UH3).

    HHS-NIH11Due Jan 8, 2027$500,000

    Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

    Renewal opportunity for ongoing NINDS-supported clinical trials needing more time and resources via U01 cooperative agreements.

    HHS-NIH11Due Mar 5, 2027

    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

    NIDCD funds clinical trials on communication disorders with FDA oversight, focus on efficacy, or high risk impact to treat or prevent such disorders.

    HHS-NIH11Due Feb 18, 2027

    NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

    Supports investigator-initiated, milestone-driven clinical trials requiring enhanced oversight for up to 7 years, with mechanistic studies as applicable and one trial per application.

    HHS-NIH11Due Feb 5, 2027